$DCGO

DocGo Inc.

No enriched coverage for $DCGO in the last 7 days.

No SEC Form 4 filings for $DCGO in the last 30 days.

Low

DocGo (NASDAQ:DCGO) Price Target Cut to $2.50 by Analysts at Stifel Nicolaus

Stifel Nicolaus has lowered its price target for DocGo (NASDAQ:DCGO) to $2.50 from $4.00, while maintaining a "buy" rating, indicating a potential upside of 218%. Despite a Q4 revenue beat and raised 2026 revenue guidance of $290M–$310M, the company faces significant execution risk due to a large EPS miss, year-over-year revenue decline, and weak margins, with the stock currently trading around $0.79. DocGo is exploring strategic alternatives to push towards profitability.

Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to long-term shareholders. The firm encourages current DocGo shareholders to contact them to discuss potential legal rights and options, including seeking corporate governance reforms or the return of funds to the company. The investigation aims to enhance shareholder value through improved company policies and oversight.